BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lindberg AA, Pál T. Strategies for development of potential candidate Shigella vaccines. Vaccine. 1993;11:168-179. [PMID: 8438615 DOI: 10.1016/0264-410x(93)90014-o] [Cited by in Crossref: 37] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Rui X, Xu Y, Wu X, Su G, Huang C. Construction of a trivalent candidateShigella vaccine strain with host-vector balanced-lethal system. Sci China C Life Sci 1997;40:52-9. [PMID: 18726299 DOI: 10.1007/BF02879107] [Reference Citation Analysis]
2 Polotsky Y, Dragunsky E, Khavkin T. Morphologic Evaluation of the Pathogenesis of Bacterial Enteric Infections - Part II. Critical Reviews in Microbiology 2008;20:185-208. [DOI: 10.3109/10408419409114554] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
3 Thirumalai K, Kim KS, Zychlinsky A. IpaB, a Shigella flexneri invasin, colocalizes with interleukin-1 beta-converting enzyme in the cytoplasm of macrophages. Infect Immun 1997;65:787-93. [PMID: 9009343 DOI: 10.1128/iai.65.2.787-793.1997] [Cited by in Crossref: 40] [Cited by in F6Publishing: 24] [Article Influence: 1.6] [Reference Citation Analysis]
4 Zheng JP, Zhang ZS, Li SQ, Liu XX, Yuan SL, Wang P, Zhan DW, Wang LC, Huang CF. Construction of a novel Shigella live-vector strain co-expressing CS3 and LTB/STm of enterotoxigenic E.coliWorld J Gastroenterol 2005; 11(22): 3411-3418 [PMID: 15948247 DOI: 10.3748/wjg.v11.i22.3411] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
5 Yao X, Wang HL, Shi ZX, Yan XY, Feng EL, Yang BL, Huang LY. Identification of RanBMP interacting with Shigella flexneri IpaC invasin by two-hybrid system of yeast. World J Gastroenterol 2003; 9(6): 1347-1351 [PMID: 12800254 DOI: 10.3748/wjg.v9.i6.1347] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
6 Levine MM, Noriega F. Vaccines to prevent bacterial enteric infections in children. Pediatr Ann 1993;22:719-25. [PMID: 8139873 DOI: 10.3928/0090-4481-19931201-07] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
7 Klee SR, Tzschaschel BD, Fält I, Kärnell A, Lindberg AA, Timmis KN, Guzmán CA. Construction and characterization of a live attenuated vaccine candidate against Shigella dysenteriae type 1. Infect Immun 1997;65:2112-8. [PMID: 9169740 DOI: 10.1128/iai.65.6.2112-2118.1997] [Cited by in Crossref: 14] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
8 Chin'ombe N, Ruhanya V. HIV/AIDS vaccines for Africa: scientific opportunities, challenges and strategies. Pan Afr Med J 2015;20:386. [PMID: 26185576 DOI: 10.11604/pamj.2015.20.386.4660] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]